|
CC-92480
|
C414305-1mg
|
≥98% |
2259648-80-9 |
1mg
|
¥ 742.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CP2 TFA
|
C414079-1mg
|
≥97% |
N/A |
1mg
|
¥ 607.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CDKI-73
|
C413829-1mg
|
Moligand™, ≥95% |
1421693-22-2 |
1mg
|
¥ 588.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(Rac)-X77
|
C412593-1mg
|
≥98% |
2144491-78-9 |
1mg
|
¥ 654.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CPD3615-A5
|
C412360-1mg
|
≥98% |
2045894-03-7 |
1mg
|
¥ 817.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
胶原I,大鼠尾巴
|
C390611-25mg
|
8-11 mg/ml in 0.01 N HCl |
N/A |
25mg
|
¥ 2007.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
二溴氯乙醛
|
C388500-10mg
|
≥90% |
64316-11-6 |
10mg
|
¥ 857.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
铜 (II) 离子载体 I
|
C355639-10mg
|
≥95% |
125769-67-7 |
10mg
|
¥ 942.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
硫酸氯喹
|
C349192-5mg
|
Moligand™, ≥98% |
132-73-0 |
5mg
|
¥ 439.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
硫酸氯喹
|
C349192-100mg
|
Moligand™, ≥98% |
132-73-0 |
100mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CEP-28122 mesylate salt
|
C346893-5mg
|
Moligand™, ≥98% |
2070009-30-0 |
5mg
|
¥ 1499.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CEP-28122 mesylate salt
|
C346893-50mg
|
Moligand™, ≥98% |
2070009-30-0 |
50mg
|
¥ 5499.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CEP-28122 mesylate salt
|
C346893-1mg
|
Moligand™, ≥98% |
2070009-30-0 |
1mg
|
¥ 449.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CEP-28122 mesylate salt
|
C346893-10mg
|
Moligand™, ≥98% |
2070009-30-0 |
10mg
|
¥ 2399.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CL-387785
|
C337834-100mg
|
≥97% |
194423-06-8 |
100mg
|
¥ 1853.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
盐酸CDKi
|
C336624-1mg
|
≥98% |
70035-83-5 |
1mg
|
¥ 736.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
西拉普利
|
C334931-5mg
|
Moligand™, ≥98% |
88768-40-5 |
5mg
|
¥ 1760.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,4'-双(9-咔唑基)-2,2'-二甲基联苯
|
C289987-250mg
|
升华级, ≥99%(HPLC) |
120260-01-7 |
250mg
|
¥ 1899.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
落新妇苷,来自黄杞
|
A464865-50mg
|
≥98% |
29838-67-3 |
50mg
|
¥ 399.9
|
现货 |
|
0 |
阿拉丁 |
|
C3,微粒体前列腺素E合酶1(mPGES-1)抑制剂
|
C287028-5mg
|
Moligand™, ≥98%(HPLC) |
1268709-57-4 |
5mg
|
¥ 1139.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
胶原酶 NB 4 来源于溶组织梭菌
|
C279013-100mg
|
EnzymoPure™, 标准级,≥ 0.10 U/mg |
9001-12-1 |
100mg
|
¥ 706.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CGP 39551,竞争性NMDA拮抗剂
|
C275038-1mg
|
≥99% |
127910-32-1 |
1mg
|
¥ 661.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
氮掺杂有序介孔碳
|
C196585-250mg
|
比表面 (m2/g):800 孔容 (cm3/g):1.1 孔径 (nm):3.9 |
64365-11-3 |
250mg
|
¥ 956.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy5 PEG 巯基, Cy5-PEG-SH
|
C163512-1mg
|
MW 3400 Da |
N/A |
1mg
|
¥ 765.9
|
期货,请咨询 |
|
0 |
阿拉丁 |